EVV (Eaton Vance Durationome Fund) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


EVV Eaton Vance Ltd Duration Income Fund EVV
45 GF Score
Price $9.21
GF Value $6.40
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Eaton Vance Durationome Fund Research & Development?

Eaton Vance Durationome Fund EVV 45 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates EVV with a GF Score™ of 45/100 and a GF Value™ of $6.40 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Eaton Vance Durationome Fund's Research & Development for the six months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Eaton Vance Durationome Fund  (AMEX:EVV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Eaton Vance Durationome Fund Research & Development Related Terms

Eaton Vance Durationome Fund Research & Development Historical Data

* Premium members only.

The historical data trend for Eaton Vance Durationome Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eaton Vance Durationome Fund Research & Development Chart

Eaton Vance Durationome Fund Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eaton Vance Durationome Fund Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
EVV
45GF Score
Eaton Vance Ltd Duration Income Fund EVV
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eaton Vance Durationome Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Eaton Vance Durationome Fund (EVV) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Eaton Vance Durationome Fund and its competitors.
Is Eaton Vance Durationome Fund's Research & Development too high?
Eaton Vance Durationome Fund's current Research & Development is $0.00 Mil. Overall, Eaton Vance Durationome Fund has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eaton Vance Durationome Fund's Research & Development compare to PTA and AOD?
Eaton Vance Durationome Fund's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Eaton Vance Durationome Fund and its competitors. Eaton Vance Durationome Fund's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eaton Vance Durationome Fund stock overvalued right now?
Based on GuruFocus' analysis, Eaton Vance Durationome Fund (EVV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.40, compared to a current price of $9.21 — trading 43.9% above its estimated fair value. The current Research & Development is $0.00 Mil. Eaton Vance Durationome Fund's overall GF Score™ is 45/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Eaton Vance Durationome Fund (EVV), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eaton Vance Durationome Fund (EVV) Overvalued in 2026?

Based on GuruFocus' analysis, Eaton Vance Durationome Fund stock appears to be overvalued. The current stock price of $9.21 is trading 43.9% above its estimated GF Value™ of $6.40. GuruFocus considers Eaton Vance Durationome Fund to be Significantly Overvalued.

Key valuation signals for EVV:

  • Research & Development: $0.00 Mil
  • GF Value™: $6.40 vs. price of $9.21 (43.9% above fair value)
  • GF Score™: 45/100 with 9 warning signs

No single metric tells the full story. See the EVV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eaton Vance Durationome Fund Business Description

Address One Post Office Square, Boston, MA, USA, 02109
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.
45GF Score

Get the complete analysis for EVV

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.21
Price
$6.40
GF Value